Suresh Garudadri1, Prescott G Woodruff2, MeiLan K Han3, Jeffrey L Curtis3, R Graham Barr4, Eugene R Bleecker5, Russell P Bowler6, Alejandro Comellas7, Christopher B Cooper8, Gerard Criner9, Mark T Dransfield10, Nadia N Hansel11, Robert Paine12, Jerry A Krishnan13, Stephen P Peters14, Annette T Hastie15, Fernando J Martinez16, Wanda K O'Neal17, David J Couper18, Neil E Alexis19, Stephanie A Christenson2. 1. Cleveland Clinic Lerner College of Medicine, Case Western Reserve University, Cleveland, OH; Division of Pulmonary, Critical Care, Allergy, and Sleep Medicine, University of California, San Francisco, San Francisco, CA. Electronic address: sureshgarudadri@gmail.com. 2. Division of Pulmonary, Critical Care, Allergy, and Sleep Medicine, University of California, San Francisco, San Francisco, CA. 3. Division of Pulmonary and Critical Care Medicine, University of Michigan, Ann Arbor, MI. 4. Department of Medicine and Department of Epidemiology, Columbia University, New York, NY. 5. Department of Medicine, University of Arizona, Tucson, AZ. 6. Department of Medicine, National Jewish Health, Denver, CO. 7. Department of Medicine, University of Iowa, Iowa City, IA. 8. School of Medicine, University of California, Los Angeles, Los Angeles, CA. 9. School of Medicine, Medicine/Pulmonary and Critical Care, Temple University, Philadelphia, PA. 10. Division of Pulmonary, Allergy, and Critical Care Medicine, University of Alabama, Birmingham, Birmingham, AL. 11. Johns Hopkins University, Baltimore, MD. 12. Internal Medicine/Pulmonary and Critical Care, University of Utah, Salt Lake City, UT. 13. Pulmonary, Critical Care, Sleep and Allergy College of Medicine, University of Illinois, Chicago, Chicago, IL. 14. Section on Pulmonary, Critical Care, Allergy & Immunologic Diseases, Wake Forest University, Winston-Salem, NC. 15. Center for Genomics and Personalized Medicine Research, Wake Forest University, Winston-Salem, NC. 16. Department of Medicine, Weill Cornell Medical College, New York, NY. 17. Marsico Lung Institute, University of North Carolina, Chapel Hill, NC. 18. Department of Biostatistics, University of North Carolina, Chapel Hill, NC. 19. Center for Environmental Medicine, Asthma and Lung Biology, University of North Carolina, Chapel Hill, NC.
Abstract
BACKGROUND: Chronic respiratory symptoms and exacerbation-like events are common among ever-smokers without airflow limitation on spirometry. The pathobiology of respiratory disease in this subgroup remains poorly defined, but may be due to underlying inflammation that overlaps with COPD or asthma. We hypothesized that symptoms, exacerbations, and functional measures of disease severity among smokers with preserved spirometry would be associated with markers of systemic inflammation, similar to what is reported in bone fide COPD, rather than elevated type 2 inflammation, which is often present in asthma. METHODS: We measured inflammatory markers associated with COPD (C-reactive protein [CRP], fibrinogen, soluble tumor necrosis factor receptors [sTNFRSF1A and sTNFRSF1B], and blood/sputum neutrophils) and type 2 inflammation (IgE and blood/sputum eosinophils) in smokers with preserved spirometry (postbronchodilator FEV1/FVC ≥ 0.70) from the Subpopulations and Intermediate Outcome Measures In COPD Study (SPIROMICS). We evaluated the relationship of these markers with respiratory symptom burden (dichotomized by a COPD assessment test score cutoff of 10, diagnosis of chronic bronchitis), exacerbations, 6-minute walk distance, and lung function on the basis of FEV1. RESULTS: CRP was associated with increased symptom burden (on the basis of COPD assessment test score and diagnosis of chronic bronchitis) and a greater number of exacerbations in the year before study enrollment. sTNFRSF1A was associated with symptom burden on the basis of COPD assessment test score. CRP and sTNFRSF1A levels negatively correlated with 6-minute walk distance. IgE and eosinophils were not associated with these outcomes. CONCLUSIONS: Markers of inflammation including CRP and sTNFRSF1A are enriched among symptomatic smokers with preserved spirometry, suggesting an overlap with the underlying pathophysiology of COPD.
BACKGROUND: Chronic respiratory symptoms and exacerbation-like events are common among ever-smokers without airflow limitation on spirometry. The pathobiology of respiratory disease in this subgroup remains poorly defined, but may be due to underlying inflammation that overlaps with COPD or asthma. We hypothesized that symptoms, exacerbations, and functional measures of disease severity among smokers with preserved spirometry would be associated with markers of systemic inflammation, similar to what is reported in bone fide COPD, rather than elevated type 2 inflammation, which is often present in asthma. METHODS: We measured inflammatory markers associated with COPD (C-reactive protein [CRP], fibrinogen, soluble tumornecrosis factor receptors [sTNFRSF1A and sTNFRSF1B], and blood/sputum neutrophils) and type 2 inflammation (IgE and blood/sputum eosinophils) in smokers with preserved spirometry (postbronchodilator FEV1/FVC ≥ 0.70) from the Subpopulations and Intermediate Outcome Measures In COPD Study (SPIROMICS). We evaluated the relationship of these markers with respiratory symptom burden (dichotomized by a COPD assessment test score cutoff of 10, diagnosis of chronic bronchitis), exacerbations, 6-minute walk distance, and lung function on the basis of FEV1. RESULTS: CRP was associated with increased symptom burden (on the basis of COPD assessment test score and diagnosis of chronic bronchitis) and a greater number of exacerbations in the year before study enrollment. sTNFRSF1A was associated with symptom burden on the basis of COPD assessment test score. CRP and sTNFRSF1A levels negatively correlated with 6-minute walk distance. IgE and eosinophils were not associated with these outcomes. CONCLUSIONS: Markers of inflammation including CRP and sTNFRSF1A are enriched among symptomatic smokers with preserved spirometry, suggesting an overlap with the underlying pathophysiology of COPD.
Authors: Stephanie A Christenson; Katrina Steiling; Maarten van den Berge; Kahkeshan Hijazi; Pieter S Hiemstra; Dirkje S Postma; Marc E Lenburg; Avrum Spira; Prescott G Woodruff Journal: Am J Respir Crit Care Med Date: 2015-04-01 Impact factor: 21.405
Authors: Jason D Keene; Sean Jacobson; Katerina Kechris; Gregory L Kinney; Marilyn G Foreman; Claire M Doerschuk; Barry J Make; Jeffrey L Curtis; Stephen I Rennard; R Graham Barr; Eugene R Bleecker; Richard E Kanner; Eric C Kleerup; Nadia N Hansel; Prescott G Woodruff; MeiLan K Han; Robert Paine; Fernando J Martinez; Russell P Bowler; Wanda K O'Neal Journal: Am J Respir Crit Care Med Date: 2017-02-15 Impact factor: 21.405
Authors: Alvar Agustí; Lisa D Edwards; Stephen I Rennard; William MacNee; Ruth Tal-Singer; Bruce E Miller; Jørgen Vestbo; David A Lomas; Peter M A Calverley; Emiel Wouters; Courtney Crim; Julie C Yates; Edwin K Silverman; Harvey O Coxson; Per Bakke; Ruth J Mayer; Bartolome Celli Journal: PLoS One Date: 2012-05-18 Impact factor: 3.240
Authors: Wanda K O'Neal; Wayne Anderson; Patricia V Basta; Elizabeth E Carretta; Claire M Doerschuk; R Graham Barr; Eugene R Bleecker; Stephanie A Christenson; Jeffrey L Curtis; Meilan K Han; Nadia N Hansel; Richard E Kanner; Eric C Kleerup; Fernando J Martinez; Bruce E Miller; Stephen P Peters; Stephen I Rennard; Mary Beth Scholand; Ruth Tal-Singer; Prescott G Woodruff; David J Couper; Sonia M Davis Journal: J Transl Med Date: 2014-01-08 Impact factor: 5.531
Authors: Gunnar R Husebø; Per S Bakke; Marianne Aanerud; Jon A Hardie; Thor Ueland; Rune Grønseth; Louise J P Persson; Pål Aukrust; Tomas M Eagan Journal: PLoS One Date: 2014-10-03 Impact factor: 3.240
Authors: Wei Sun; Katerina Kechris; Sean Jacobson; M Bradley Drummond; Gregory A Hawkins; Jenny Yang; Ting-Huei Chen; Pedro Miguel Quibrera; Wayne Anderson; R Graham Barr; Patricia V Basta; Eugene R Bleecker; Terri Beaty; Richard Casaburi; Peter Castaldi; Michael H Cho; Alejandro Comellas; James D Crapo; Gerard Criner; Dawn Demeo; Stephanie A Christenson; David J Couper; Jeffrey L Curtis; Claire M Doerschuk; Christine M Freeman; Natalia A Gouskova; MeiLan K Han; Nicola A Hanania; Nadia N Hansel; Craig P Hersh; Eric A Hoffman; Robert J Kaner; Richard E Kanner; Eric C Kleerup; Sharon Lutz; Fernando J Martinez; Deborah A Meyers; Stephen P Peters; Elizabeth A Regan; Stephen I Rennard; Mary Beth Scholand; Edwin K Silverman; Prescott G Woodruff; Wanda K O'Neal; Russell P Bowler Journal: PLoS Genet Date: 2016-08-17 Impact factor: 5.917
Authors: Stephen Kaptoge; Emanuele Di Angelantonio; Gordon Lowe; Mark B Pepys; Simon G Thompson; Rory Collins; John Danesh Journal: Lancet Date: 2009-12-22 Impact factor: 79.321
Authors: Michael Emmet O'Brien; Richard H Zou; Nathan Hyre; Joseph K Leader; Carl R Fuhrman; Frank C Sciurba; Mehdi Nouraie; Jessica Bon Journal: Thorax Date: 2021-12-01 Impact factor: 9.102
Authors: Anita L Oh; Richard A Mularski; Igor Barjaktarevic; R Graham Barr; Russell P Bowler; Alejandro P Comellas; Christopher B Cooper; Gerard J Criner; MeiLan K Han; Nadia N Hansel; Eric A Hoffman; Richard E Kanner; Jerry A Krishnan; Robert Paine; Trisha M Parekh; Stephen P Peters; Stephanie A Christenson; Prescott G Woodruff Journal: Ann Am Thorac Soc Date: 2021-11
Authors: Fernando Diaz Del Valle; Jonathan K Zakrajsek; Sung-Joon Min; Patricia B Koff; Harold W Bell; Keegan A Kincaid; Daniel N Frank; Vijay Ramakrishnan; Moumita Ghosh; R William Vandivier Journal: Chest Date: 2022-03-07 Impact factor: 10.262